MarketFriction

Honasa Consumer Ltd

NSE HONASA · BSE 544014 · Personal Care
₹427.90 -0.80%
NSE close2026-10-01
52 week range248.40 - 509.80
Market cap₹14,399 Cr.
P/E57.0
IPO 2023 · +32% since Nifty 500Smallcap 250 Price band 20% Delivery 49.5%

Price

Drag to pan, scroll or pinch to zoom. Ruler (or Shift + drag) measures a move.Dashed lines: 52 week high and low. Prices adjusted for splits and bonuses.

Financials

Consolidated, Rs crore
Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Sales496488471554462518534595538602657756
Expenses456454438508493491507549490536580646
Operating Profit40343346-31262746486577110
OPM %8%7%7%8%-7%5%5%8%9%11%12%15%
Other Income71119192019212420161923
Interest233333333333
Depreciation681091113121112111110
Profit before tax39353952-24293256536782119
Tax %25%25%22%23%-24%12%22%26%26%25%15%24%
Net Profit29263040-1926254139506990
EPS in Rs2.160.800.941.24-0.570.800.771.271.211.542.132.77
Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales4609431,4931,9202,0672,3922,553
Expenses1,7949321,4701,7821,9972,1562,252
Operating Profit-1,334122313870236300
OPM %-290%1.2%1.5%7%3.4%10%12%
Other Income1221-13249777977
Interest1379131313
Depreciation272531454444
Profit before tax-1,32522-14114790257321
Tax %1%36%7%25%19%22%
Net Profit-1,33214-15111173200249
EPS in Rs-1,306,098.0415,262.14-10.473.452.246.157.65
Dividend Payout %0%0%0%0%0%49%
10 Years5 Years3 YearsTTM1 YearLast Year
Compounded Sales Growth%39%17%21%
Compounded Profit Growth%17%118%242%
Stock Price CAGR%%%57%
Return on Equity%%%16%
Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital0.010.01136324325325
Reserves-1,765-1,087-1,3237718551,086
Borrowings1,9541,8531,885131136135
Other Liabilities114271288413492560
Total Liabilities3031,0369861,6401,8082,107
Fixed Assets21342252299302489
CWIP020000
Investments164339260292305272
Other Assets1173544741,0491,2011,346
Total Assets3031,0369861,6401,8082,107
Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity3045-52235102141
Cash from Investing Activity-21-50540-470-145-17
Cash from Financing Activity-1481-14337-31-38
Net Cash Flow821-26102-7486
Free Cash Flow2942-6322482134
CFO/OP-3%470%-172%194%139%85%
Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days272832302330
Inventory Days11486998310592
Days Payable221219161185212193
Cash Conversion Cycle-80-105-30-71-84-71
Working Capital Days-2-128-10-17-9
ROCE %5%3%16%8%19%
Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters35.34%35.07%35.07%34.98%35.03%34.99%34.99%34.97%35.54%35.54%35.47%
FIIs10.12%12.22%13.95%19.31%15.44%15.55%16.09%15.50%14.62%13.74%13.64%
DIIs17.58%15.91%17.36%17.49%18.45%18.49%18.90%19.15%18.64%19.24%21.58%
Public36.96%36.80%33.62%28.23%31.07%30.97%30.02%30.36%31.19%31.48%29.30%
No. of Shareholders53,18651,09544,82465,72494,58592,00881,09081,84182,09178,18785,336

Fundamentals

Market Cap₹ 14,399 Cr.
Current Price₹ 442
Stock P/E57.0
Book Value₹ 43.4
ROCE19.2 %
ROE15.7 %
Dividend Yield0.68 %
Face Value₹ 10.0
Compounded Sales Growth (TTM)21%
Compounded Profit Growth (TTM)242%
Consolidated figures.
Valuation
Market capRs 13,951 Cr
Enterprise valueRs 15,715 Cr
P/E (TTM)56.06x
Price to book-12.83x
Price to sales5.47x
EV / EBITDA41.59x
EV / EBIT47.08x
EV / sales6.16x
Price to cash flow312.86x
Earnings yield1.78%
Profitability
Operating margin (excl. other income)1.22%
Operating margin (incl. other income)3.43%
EBITDA margin14.80%
Pre-tax margin12.57%
Net profit margin9.75%
Net margin, latest quarter11.94%
ROE-1.10%
ROCE5.33%
ROA2.35%
ROIC (approx.)31.69%
Tax rate35.67%
Other income / net worth-1.92%
Growth
Sales growth (latest year)105.11%
Sales growth QoQ15.05%
Profit growth QoQ30.44%
Sales growth YoY (latest quarter)27.00%
Profit growth YoY (latest quarter)118.36%
Per share
EPS (TTM)Rs 7.63
EPS (latest year)Rs 14,906.13
EPS (latest quarter)Rs 2.77
Book value per shareRs -33.35
Sales per shareRs 78.30
Cash flow per shareRs 1.37
Free cash flow per shareRs 4.11
Efficiency
Asset turnover0.91x
Fixed asset turnover2.76x
Inventory turnover4.53x
Inventory days81 days
Debtor days28 days
Debtors turnover12.96x
Creditor days193 days
Cash conversion cycle-71 days
Working capital days-9 days
Leverage
Total debtRs 1,853 Cr
Cash and bankRs 88 Cr
Net debtRs 1,765 Cr
Debt to equity-1.70x
Net debt / EBITDA4.67x
Interest coverage25.92x
Current ratio (filing 2026-03-31)1.69x
Quick ratio (filing 2026-03-31)1.40x
Trade payables (filing 2026-03-31)Rs 378 Cr
Owners' fund to total sources-104.92%
Debt to assets178.77%
Cash flow
Cash from Operating Activity (latest year)Rs 45 Cr
Cash from Investing Activity (latest year)Rs -505 Cr
Cash from Financing Activity (latest year)Rs 481 Cr
Net Cash Flow (latest year)Rs 21 Cr
Free cash flow (latest year)Rs 134 Cr
FCFE (approx.: FCF + change in debt)Rs 33 Cr
Cash from ops / profit, 5 years1.91x
Sales to cash flow21.16x
Statement figures
Net sales (TTM)Rs 2,553 Cr
Net sales (latest year)Rs 943 Cr
Sales (latest quarter)Rs 756 Cr
Operating profit excl. other income (latest year)Rs 12 Cr
Operating profit (latest quarter)Rs 110 Cr
Other income (TTM)Rs 77 Cr
EBITDA (TTM)Rs 378 Cr
PBDT (TTM)Rs 365 Cr
Profit before tax (TTM)Rs 321 Cr
Tax (latest year)Rs 8 Cr
Net profit (TTM)Rs 249 Cr
Net profit (latest year)Rs 16 Cr
Net profit (latest quarter)Rs 90 Cr
Depreciation (TTM)Rs 44 Cr
Depreciation (latest quarter)Rs 10 Cr
Interest (TTM)Rs 13 Cr
Cost of goods sold (latest year)Rs 304 Cr
Total expenditure (latest year)Rs 932 Cr
Total income (latest year)Rs 964 Cr
Share capitalRs 0 Cr
ReservesRs -1,087 Cr
Shareholders' fundsRs -1,087 Cr
Total assetsRs 1,036 Cr
Net blockRs 342 Cr
Capital work in progressRs 2 Cr
InvestmentsRs 339 Cr
ReceivablesRs 73 Cr
InventoryRs 67 Cr
Other liabilitiesRs 271 Cr
Shares outstanding (crore)32.60
Ownership
Promoter holding35.47% (+0.48 in a year)
Computed by MarketFriction from the consolidated statements. Returns use average balances.
Not enough history to build valuation bands (needs two years of profits and prices).
PeriodHONASANifty 50Difference
1 week-9.5%-2.8% -6.7 pts
1 month-9.6%-6.8% -2.8 pts
3 months-7.3%-7.6% +0.3 pts
6 months+43.5%+0.4% +43.1 pts
1 year+45.1%-9.9% +55.0 pts
2 years-12.4%-13.6% +1.1 pts
77 mutual fund schemes hold about ₹960 Cr. Over three months 61 bought more and 12 sold (share counts, price move removed).
FundWeightEst. Cr3m shares
Bandhan Large & Mid Cap Fund0.64%135 +42%
Helios Flexi Cap Fund1.30%114 +37%
Mirae Asset Great Consumer Fund1.95%92 -7%
Bandhan Innovation Fund2.27%60 -7%
Nippon India Innovation Fund1.88%58 +6%
JM Flexi Cap Fund0.95%49 +92%
TRUSTMF Small Cap Fund1.53%44 +8%
Union Innovation & Opp Fund2.41%30 +2%
Bandhan Aggressive Hybrid Fund1.06%28 +0%
Aditya Birla SL Business Cycle Fund1.44%26 +7%
Bandhan Large Cap Fund0.98%21 +12%
Union Flexi Cap Fund0.83%20 +10%
Helios Mid Cap Fund0.82%18 -9%
Helios Small Cap Fund1.25%18 -19%
Union Small Cap Fund0.63%17 +31%
Union Multicap Fund1.02%16 -10%
Samco Active Momentum Fund2.10%16 +100%
JioBlackRock Flexi Cap Fund0.46%15 +11%
Union Small Cap Fund0.63%15 +31%
TRUSTMF Flexi Cap Fund1.34%14 +6%
Nippon India Active Momentum Fund2.19%12 -8%
TRUSTMF Multi Cap Fund1.36%11 +0%
Nippon India Nifty Smallcap 250 Index Fund0.30%10 +9%
ICICI Pru FMCG Fund0.62%10 +100%
JM Focused Fund3.45%10 +45%

Red flags

F-score 7 of 8
seriousNegative equity Shareholders' equity is negative
lookProfit leans on other income Other income was 93% of pre-tax profit in 2026
Checks on the latest reported years: cash vs profit, accruals, receivables and inventory vs sales, dilution, debt, interest cover, equity, other income, losses, and auditor, top-management, insolvency and regulator filings in the last 12 months. A flag asks for an explanation; it is not a verdict.

Latest quarter

Jun 2026
Sales ₹756 Cr +27.1% vs Jun 2025. Net profit ₹90 Cr +119.5%.

Activity

Compare
CompanyMcap (Cr)P/EROCE
Godrej Consumer Products Ltd87,49342.118.8 %
Dabur India Ltd67,48134.020.3 %
Colgate-Palmolive (India) Ltd48,55235.5108 %
Cupid Ltd38,72628233.9 %
Gillette India Ltd22,69434.090.7 %
Procter & Gamble Hygiene and Health Care Ltd22,30528.2157 %
Emami Ltd16,63322.028.1 %
Bajaj Consumer Care Ltd6,43928.930.0 %
Anondita Medicare Ltd2,08562.343.8 %
Recode Studios Ltd45440.574.1 %
Radix Industries (India) Ltd20369.219.6 %
Macobs Technologies Ltd18965.311.0 %
H. R. Hygiene Products Ltd15613.730.4 %
Thrive Future Habitats Limited100-7.67 %
Aakaar Medical Technologies Ltd9514.318.5 %
DateClientSideQtyPrice
2026-09-29Sequoia Capital Global Growth Fund Iii - U.S./ India Annex Fund L.P.SELL2,502,289450.00
2026-09-29Peak Xv Partners Investments ViSELL10,755,495450.22
2026-09-29Icici Prudential Life Insurance Company LimitedBUY1,777,777450.00
2026-09-29Franklin Templeton Mutual FundBUY3,333,333450.00
Ex-dateActionFactor
2026-08-28Dividend - Rs 3 Per Share
2024-08-22Annual General Meeting
DateTypeWhat it says
2026-09-29Shareholder meetingVoting results.
2026-09-28Shareholder meetingProceedings of Annual General Meeting held on September 28, 2026
2026-09-11Concall / analyst meetSchedule of Meeting with Analysts/Investors
2026-09-11Concall / analyst meetSchedule of Meeting with Analysts/Investors
2026-09-08UpdatesUpdate on Senior Management
2026-09-03Shareholder meetingNotice of 10th Annual General Meeting
2026-08-26General UpdatesCommunication regarding tax deduction at source on final dividend for FY 2025-26
2026-08-25General UpdatesUpdate on proposed acquisition of Fluence Pharma Private Limited
2026-08-19Concall / analyst meetTranscript of Earnings Conference Call held on August 13, 2026
2026-08-13Concall / analyst meetAudio recording of Earnings Conference Call August 13, 2026
2026-08-13Monitoring Agency ReportMonitoring Agency Report issued by ICRA Limited, Monitoring Agency, for the quarter ended June 30, 2026
2026-08-13UpdatesAnnual General Meeting.
2026-08-13Record DateRecord date for determining the eligibility of members entitled to receive final dividend of Rs. 3/- per equity share for the financial year 2025-26.
2026-08-13Press ReleaseA press release dated August 13, 2026, titled "HONASA CONSUMER DELIVERS HIGHEST EVER QUARTERLY REVENUE AND PROFIT IN Q1FY27".
2026-08-13Investor PresentationInvestor Presentation
2026-08-13Board meeting outcomeOutcome of Board Meeting held today i.e. August 13, 2026
2026-08-11Concall / analyst meetSchedule of Meeting with Analysts/Investors
2026-08-08UpdatesCassation Court, Dubai, UAE Judgment in the matter of RSM General Trading LLC
2026-08-06UpdatesUpdate on Senior Management .
2026-07-31Concall / analyst meetSchedule of Q1 FY 2027 Earnings Conference Call
2026-07-09UpdatesQuarterly Update Q1 FY2026-27.
2026-07-07General UpdatesIncorporation of a wholly owned subsidiary Honasa Health Private Limited
2026-06-26UpdatesFavorable Rectification Order in Arbitration Proceedings against RSMM General Trading LLC.
2026-06-23Press ReleaseA press release dated Jun 23, 2026, titled "Honasa Consumer Limited Enters Nutraceuticals with Majority Stake Acquisition in Fluence Pharma".
2026-06-23AcquisitionApproval for acquisition of Fluence Pharma Private Limited and incorporation of a wholly owned subsidiary
Company filings to NSE, newest first. Routine notices (trading window, newspaper copies) are left out. Click a row for the filing.
No short selling reported to NSE in our files.
Short sales disclosed by brokers to NSE, by trade date. Collected since late September 2026.
Scrip PE is greater than 50 (4 trailing quarters)

Quick answers

What is the market cap of Honasa Consumer Ltd?

Honasa Consumer Ltd (HONASA) has a market capitalisation of Rs 14,399 Cr. at the 2026-10-01 close.

What is the P/E ratio of Honasa Consumer Ltd?

Honasa Consumer Ltd trades at a P/E of 57.0 on trailing twelve-month profit, at the 2026-10-01 close.

What were Honasa Consumer Ltd's latest quarterly results?

In the Jun 2026 quarter, Honasa Consumer Ltd sales was Rs 756 Cr (+27.1% vs Jun 2025) and net profit was Rs 90 Cr.

What is the 52-week high and low of Honasa Consumer Ltd?

The 52-week high is Rs 509.80 and the 52-week low is Rs 248.40.

Data: NSE and BSE daily reports, company filings. Numbers only, not investment advice, not a SEBI-registered research service.AboutMethodologyFAQResearchContactTermsPrivacyDisclaimerUpdated 2026-10-03